News

As part of its role to support the assessment of safety of vaccines being evaluated in CEPI funded clinical trials, the Safety Platform[...]

Recent news of the possible complications of blood clots – or Thrombosis with Thrombocytopenia Syndrome (TTS) – following the AstraZeneca/Oxford and Johnson &[...]

 The Benefit-Risk Assessment of Vaccines by TechnolOgy (BRAVATO) working group has developed standardized templates for the collection of key information for the development, efficacy, and[...]

The Centers for Disease Control and Prevention (CDC) has invested in The Task Force for Global Health (TFGH) to help low and middle income counties[...]

SPEAC has completed a second update of the COVID-19 clinical literature covering the period of August 8 through November 13th 2020. Based on this[...]

Robert Chen, the Scientific Director of Brighton Collaboration, discussed the safety profiles of COVID-19 vaccines with the Coalition for Epidemic Preparedness Innovations (CEPI). To[...]

Brighton Collaboration (BC) has been added to the Vaccine Safety Net (VSN). VSN is a global network of websites, established by the World Health Organization[...]

Digital apps have much potential for improving the quality of safety data collected during both pre and post-introduction of new vaccines, including SARS-COV-2 candidate[...]

The Coalition for Epidemic Preparedness Innovation (CEPI) has partnered with the Brighton Collaboration to support the safety assessment of its candidate vaccines, including[...]

Our previous post entitled Transition of Brighton Collaboration informed you of several new developments to strengthen the Brighton Collaboration, including our move to the Task[...]

The Coalition for Epidemic Preparedness Innovations (CEPI) and the Brighton Collaboration, based in Atlanta at The Task Force for Global Health, announced the launch of[...]

Dear Partners and Visitors As announced on the 21st of May 2019, the Brighton Collaboration will be dissolved as a Partnership under Swiss law[...]